Company
WinSanTor
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
is a private, clinical-stage biotechnology company concentrating on discovering and developing treatments of peripheral neuropathies. They currently focused on their lead drug, WST-057, which is in Phase 2 of a clinical trial in Canada.
Loading relationship preview